MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from maturities
of marketable...
$139,006K
Proceeds from offering of
common stock, net of...
$42,848K
Proceeds from the sale of
equipment
$269K
Issuance of common stock
under benefit plans
$424K
Proceeds from exercise of
stock options
$70K
Net cash provided by
investing activities
$138,668K
Net cash provided by
financing activities
$40,470K
Canceled cashflow
$607K
Canceled cashflow
$2,872K
Net increase
(decrease) in cash, cash...
$13,897K
Canceled cashflow
$165,241K
Purchases of property and
equipment
$607K
Right-of-use assets
-$11,584K
Stock-based compensation
expense
$10,000K
Interest related to sale
of future revenues
$6,171K
Depreciation
$5,277K
Impairment of held for sale
assets
$3,758K
Loss on disposal of
fixed assets
-$2,193K
Accounts receivable
-$1,090K
Prepaid expenses and
other current assets
-$1,062K
Other non-current
assets
-$1,040K
Other non-current
liabilities
$192K
Repayment on sale of future
revenues
$2,872K
Net cash used in
operating activities
-$165,241K
Canceled cashflow
$42,367K
Net loss
-$160,060K
Deferred revenue
-$15,916K
Accrued expenses
-$13,184K
Operating lease
liabilities
-$12,081K
Accounts payable
-$2,888K
Accrued interest on sale
of future revenues
-$2,128K
Net accretion of
discounts on marketable...
$902K
Other non-cash items,
net
$449K
Back
Back
Cash Flow
source: myfinsight.com
Editas Medicine, Inc. (EDIT)
Editas Medicine, Inc. (EDIT)